Ahmed El-Tahtawy
Pfizer Inc, USA
Biography
Ahmed has completed his pharmacy degree and his PhD more than 20 years ago from USC University. He had a postdoctoralfellowship from FDA before jioing as a clinical Pharmacology reviewer.. He is now a director of Clinical Pharmacology in Pfizer, where he Integrate advanced analysis in late phase drug development in order to “fill the gaps” not addressed directly by traditional confirmatory clinical trials. The implementation of these inferential methods helped evaluate benefit/risk in special populations (Pediatrics, Elderly, patient subgroups, new indication, etc...). These inferential methods played a major role in the process of evidence synthesis, providing a strong basis for decision making.